| |  Online-Ressource |
|---|
| Verfasst von: | Tini, Elvira [VerfasserIn]  |
|---|
| | Smigielski, Lukasz [VerfasserIn] |
|---|
| | Romanos, Marcel [VerfasserIn] |
|---|
| | Wewetzer, Christoph [VerfasserIn] |
|---|
| | Karwautz, Andreas [VerfasserIn] |
|---|
| | Reitzle, Karl [VerfasserIn] |
|---|
| | Correll, Christoph U. [VerfasserIn] |
|---|
| | Plener, Paul L. [VerfasserIn] |
|---|
| | Malzahn, Uwe [VerfasserIn] |
|---|
| | Heuschmann, Peter [VerfasserIn] |
|---|
| | Unterecker, Stefan [VerfasserIn] |
|---|
| | Scherf-Clavel, Maike [VerfasserIn] |
|---|
| | Rock, Hans [VerfasserIn] |
|---|
| | Antony, Gisela [VerfasserIn] |
|---|
| | Briegel, Wolfgang [VerfasserIn] |
|---|
| | Fleischhaker, Christian [VerfasserIn] |
|---|
| | Banaschewski, Tobias [VerfasserIn] |
|---|
| | Hellenschmidt, Tobias [VerfasserIn] |
|---|
| | Imgart, Hartmut [VerfasserIn] |
|---|
| | Kaess, Michael [VerfasserIn] |
|---|
| | Kölch, Michael [VerfasserIn] |
|---|
| | Renner, Tobias [VerfasserIn] |
|---|
| | Reuter-Dang, Su-Yin [VerfasserIn] |
|---|
| | Rexroth, Christian [VerfasserIn] |
|---|
| | Schulte-Körne, Gerd [VerfasserIn] |
|---|
| | Theisen, Frank [VerfasserIn] |
|---|
| | Fekete, Stefanie [VerfasserIn] |
|---|
| | Taurines, Regina [VerfasserIn] |
|---|
| | Gerlach, Manfred [VerfasserIn] |
|---|
| | Egberts, Karin M. [VerfasserIn] |
|---|
| | Walitza, Susanne [VerfasserIn] |
|---|
| Titel: | Therapeutic drug monitoring of sertraline in children and adolescents |
|---|
| Titelzusatz: | a naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder |
|---|
| Verf.angabe: | Elvira Tini, Lukasz Smigielski, Marcel Romanos, Christoph Wewetzer, Andreas Karwautz, Karl Reitzle, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Tobias Banaschewski, Tobias Hellenschmidt, Hartmut Imgart, Michael Kaess, Michael Kölch, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank Theisen, Stefanie Fekete, Regina Taurines, Manfred Gerlach, Karin Maria Egberts, Susanne Walitza |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 26 February 2022 |
|---|
| Umfang: | 11 S. |
|---|
| Fussnoten: | Gesehen am 29.08.2022 |
|---|
| Titel Quelle: | Enthalten in: Comprehensive psychiatry |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier, 1960 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 115(2022), Artikel-ID 152301, Seite 1-11 |
|---|
| ISSN Quelle: | 1532-8384 |
|---|
| Abstract: | BACKGROUND: Sertraline is a selective serotonin reuptake inhibitor with specific indications in child and adolescent psychiatry. Notwithstanding its frequent use and clinical benefits, the relationship between pharmacokinetics, pharmacodynamics, efficacy, and tolerability of sertraline across indications, particularly in non-adult patients, is not fully understood. - METHOD: This naturalistic therapeutic drug monitoring (TDM) study was conducted in a transdiagnostic sample of children and adolescents treated with sertraline (n = 78; mean age, 14.22 ± 2.39; range, 7-18 years) within the prospective multicenter "TDM-VIGIL" project. Associations between dose, serum concentration, and medication-specific therapeutic and side effects based on the Clinical Global Impression scale were examined. Tolerability was measured qualitatively with the 56-item Pediatric Adverse Event Rating Scale. - RESULTS: A strong linear positive dose-serum concentration relationship (with dose explaining 45% of the variance in concentration) and significant effects of weight and co-medication were found. Neither dose nor serum concentration were associated with side effects. An overall mild-to-moderate tolerability profile of sertraline was observed. In contrast with the transdiagnostic analysis that did not indicate an effect of concentration, when split into depression (MDD) and obsessive-compulsive disorder (OCD) diagnoses, the probability of clinical improvement significantly increased as both dose and concentration increased for OCD, but not for MDD. - CONCLUSIONS: This TDM-flexible-dose study revealed a significant diagnosis-specific effect between sertraline serum concentration and clinical efficacy for pediatric OCD. While TDM already guides clinical decision-making regarding compliance, dose calibration, and drug-drug interactions, combining TDM with other methods, such as pharmacogenetics, may facilitate a personalized medicine approach in psychiatry. |
|---|
| DOI: | doi:10.1016/j.comppsych.2022.152301 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.comppsych.2022.152301 |
|---|
| | DOI: https://doi.org/10.1016/j.comppsych.2022.152301 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Adolescent |
|---|
| | antidepressants |
|---|
| | Child |
|---|
| | Drug Monitoring |
|---|
| | Humans |
|---|
| | Obsessive-Compulsive Disorder |
|---|
| | pharmacovigilance |
|---|
| | Prospective Studies |
|---|
| | selective serotonin reuptake inhibitors |
|---|
| | Serotonin Uptake Inhibitors |
|---|
| | Sertraline |
|---|
| | steady state concentration |
|---|
| | TDM |
|---|
| K10plus-PPN: | 1815324317 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Therapeutic drug monitoring of sertraline in children and adolescents / Tini, Elvira [VerfasserIn]; 26 February 2022 (Online-Ressource)
